Blueberries Medical Corp.
BBRRF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -38.5% | 4.8% | -79.2% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 69.3% | 44% | 39.3% | 30.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $1 | $0 |
| SG&A Expenses | $0 | $0 | $1 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $1 | $0 |
| Operating Income | -$0 | -$0 | -$1 | -$0 |
| % Margin | -560.4% | -339.1% | -1,383.4% | -70.1% |
| Other Income/Exp. Net | $0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$0 | -$0 | -$1 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$0 | -$1 | -$0 |
| % Margin | -381.2% | -349.2% | -1,406.1% | -145.6% |
| EPS | 0 | -0 | -0.002 | -0.001 |
| % Growth | 100% | 78.9% | -90% | – |
| EPS Diluted | 0 | -0 | -0.002 | -0.001 |
| Weighted Avg Shares Out | 495 | 495 | 405 | 399 |
| Weighted Avg Shares Out Dil | 495 | 495 | 405 | 399 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$1 | -$0 |
| % Margin | -462.9% | -307.2% | -1,336.3% | -135.3% |